Cargando…
Combination of IGF-1 gene manipulation and 5-AZA treatment promotes differentiation of mesenchymal stem cells into cardiomyocyte-like cells
Mesenchymal stem cell (MSC) transplantation has been proposed as a promising therapeutic strategy for ischemic myocardium repair following myocardial infarction. Differentiation of MSCs into cardiomyocyte-like cells prior to cell transplantation is advantageous in improving their potential clinical...
Autores principales: | LI, JUN, ZHU, KAI, WANG, YULIN, ZHENG, JIAYU, GUO, CHANGFA, LAI, HAO, WANG, CHUNSHENG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262510/ https://www.ncbi.nlm.nih.gov/pubmed/25351395 http://dx.doi.org/10.3892/mmr.2014.2812 |
Ejemplares similares
-
Inhibition of IGF-1 receptor kinase blocks the differentiation into cardiomyocyte-like cells of BMSCs induced by IGF-1
por: Gong, Haibin, et al.
Publicado: (2017) -
Differentiation of mesenchymal stem cells from human amniotic fluid to cardiomyocyte-like cells
por: Markmee, Runchana, et al.
Publicado: (2017) -
Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair
por: Zhu, Kai, et al.
Publicado: (2014) -
Effect of ascorbic acid on differentiation of human amniotic fluid mesenchymal stem cells into cardiomyocyte-like cells
por: Markmee, Runchana, et al.
Publicado: (2019) -
Mechanotransduction of mesenchymal stem cells (MSCs) during cardiomyocytes differentiation
por: Raman, Narmadaa, et al.
Publicado: (2022)